Oncology
Obi Pharma Inc. is focused on breast cancer research, with activity centered on triple negative breast cancer and related treatment development.
- Triple negative breast cancer
- Breast cancer
- Oncology
The sponsor’s clinical work in this area reflects interest in disease-specific therapeutic strategies for aggressive malignancies with limited targeted treatment options.
Cancer immunotherapy
Its research portfolio includes immunologically directed treatment development for solid tumors, with emphasis on approaches designed to support anti-tumor activity in breast cancer.
- Immunotherapy
- Solid tumors
- Anti-tumor treatment
Clinical interest extends to therapies aimed at improving outcomes in patients with advanced or high-risk disease.
Therapeutic vaccine development
The sponsor supports research into vaccine-based cancer therapy, including antigen-targeted strategies for neoplastic disease.
- Cancer vaccine
- Antigen-targeted therapy
- Neoplastic disease
This area of interest aligns with efforts to explore immune-mediated control of tumor growth in breast oncology.
